Aytu Biopharma (AYTU) EBT Margin Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) EBT Margin Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -691.00 |
| Sep 30, 2025 | 4,600.00 |
| Jun 30, 2025 | -7,946.00 |
| Mar 31, 2025 | 8,607.00 |
| Dec 31, 2024 | 17,288.00 |
| Sep 30, 2024 | 35,150.00 |
| Jun 30, 2024 | 24,955.00 |
| Mar 31, 2024 | 17,637.00 |
| Dec 31, 2023 | 26,809.00 |
| Sep 30, 2023 | 20,207.00 |
| Jun 30, 2023 | 48,665.00 |
| Mar 31, 2023 | 120,700.00 |
| Dec 31, 2022 | 37,321.00 |
| Sep 30, 2022 | 41,970.00 |
| Jun 30, 2022 | 74,895.00 |
| Mar 31, 2022 | 33,269.00 |
| Dec 31, 2021 | 52,760.00 |
| Sep 30, 2021 | 78,666.00 |
| Jun 30, 2021 | 155,227.00 |
| Dec 31, 2020 | 64,732.00 |